Hypometabolism as a therapeutic target in Alzheimer's disease

被引：98

作者：

Costantini, Lauren C. ^{[1
]}

Barr, Linda J. ^{[1
]}

Vogel, Janet L. ^{[1
]}

Henderson, Samuel T. ^{[1
]}

机构：

[1] Accera Inc, Interlocken Crescent, Broomfield, CO 80021 USA

来源：

BMC NEUROSCIENCE | 2008年 / 9卷 / Suppl 2期

关键词：

D O I：

10.1186/1471-2202-9-S2-S16

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

The pathology of Alzheimer's disease ( AD) is characterized by cerebral atrophy in frontal, temporal, and parietal regions, with senile plaques, dystrophic neurites, and neurofibrillar tangles within defined areas of the brain. Another characteristic of AD is regional hypometabolism in the brain. This decline in cerebral glucose metabolism occurs before pathology and symptoms manifest, continues as symptoms progress, and is more severe than that of normal aging. Ketone bodies are an efficient alternative fuel for cells that are unable to metabolize glucose or are 'starved' of glucose. AC-1202 is designed to elevate serum ketone levels safely. We previously showed that treatment with AC-1202 in patients with mild-to-moderate AD improves memory and cognition. Treatment outcomes were influenced by apolipoprotein E genotype status. These data suggest that AC-1202 may be an effective treatment for cognitive dysfunction by providing an alternative substrate for use by glucose-compromised neurons.

引用

页数：9

共 58 条

[41] Declining brain activity in cognitively normal apolipoprotein E ε4 heterozygotes:: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease [J].

Reiman, EM ;

Caselli, RJ ;

Chen, KW ;

Alexander, GE ;

Bandy, D ;

Frost, J .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (06) :3334-3339

[42] Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease [J].

Risner, M. E. ;

Saunders, A. M. ;

Altman, J. F. B. ;

Ormandy, G. C. ;

Craft, S. ;

Foley, I. M. ;

Zvartau-Hind, M. E. ;

Hosford, D. A. ;

Roses, A. D. .

PHARMACOGENOMICS JOURNAL, 2006, 6 (04) :246-254

[43] INSULIN, KETONE-BODIES, AND MITOCHONDRIAL ENERGY TRANSDUCTION [J].

SATO, K ;

KASHIWAYA, Y ;

KEON, CA ;

TSUCHIYA, N ;

KING, MT ;

RADDA, GK ;

CHANCE, B ;

CLARKE, K ;

VEECH, RL .

FASEB JOURNAL, 1995, 9 (08) :651-658

[44] Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease [J].

Small, GW ;

Ercoli, LM ;

Silverman, DHS ;

Huang, SC ;

Komo, S ;

Bookheimer, SY ;

Lavretsky, H ;

Miller, K ;

Siddarth, P ;

Rasgon, NL ;

Mazziotta, JC ;

Saxena, S ;

Wu, HM ;

Mega, MS ;

Cummings, JL ;

Saunders, AM ;

Pericak-Vance, MA ;

Roses, AD ;

Barrio, JR ;

Phelps, ME .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (11) :6037-6042

[45] Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease [J].

Stokin, GB ;

Lillo, C ;

Falzone, TL ;

Brusch, RG ;

Rockenstein, E ;

Mount, SL ;

Raman, R ;

Davies, P ;

Masliah, E ;

Williams, DS ;

Goldstein, LSB .

SCIENCE, 2005, 307 (5713) :1282-1288

[46] Axonal transport and Alzheimer's disease [J].

Stokin, Gorazd B. ;

Goldstein, Lawrence S. B. .

ANNUAL REVIEW OF BIOCHEMISTRY, 2006, 75 :607-627

[47]

STONE WS, 1992, PSYCHOBIOLOGY, V20, P270

[48] Induction of ketosis may improve mitochondrial function and decrease steady-state amyloid-β precursor protein (APP) levels in the aged dog [J].

Studzinski, Christa M. ;

MacKay, William A. ;

Beckett, Tina L. ;

Henderson, Samuel T. ;

Murphy, M. Paul ;

Sullivan, Patrick G. ;

Burnham, W. McIntyre .

BRAIN RESEARCH, 2008, 1226 :209-217

[49] β-hydroxybutyrate, a cerebral function improving agent, protects rat brain against ischemic damage caused by permanent and transient focal cerebral ischemia [J].

Suzuki, M ;

Kitamura, Y ;

Mori, S ;

Sato, K ;

Dohi, S ;

Sato, T ;

Matsuura, A ;

Hiraide, A .

JAPANESE JOURNAL OF PHARMACOLOGY, 2002, 89 (01) :36-43

[50] Effect of β-hydroxybutyrate, a cerebral function improving agent, on cerebral hypoxia, anoxia and ischemia in mice and rats [J].

Suzuki, M ;

Sato, K ;

Dohi, S ;

Sato, T ;

Matsuura, A ;

Hiraide, A .

JAPANESE JOURNAL OF PHARMACOLOGY, 2001, 87 (02) :143-150

← 1 2 3 4 5 6 →